The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR -T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
Pre-publication versions of this article are available by contacting email@example.com.
|8 Jun 2018||Submitted||Original manuscript|
|12 Oct 2018||Reviewed||Reviewer Report - Antoinette Wozniak|
|13 Oct 2018||Reviewed||Reviewer Report - Kadoaki Ohashi|
|16 Oct 2018||Reviewed||Reviewer Report - Chong-Rui Xu|
|30 Oct 2018||Author responded||Author comments - Akihiro Yoshimura|
|Resubmission - Version 2|
|30 Oct 2018||Submitted||Manuscript version 2|
|1 Nov 2018||Reviewed||Reviewer Report - Antoinette Wozniak|
|6 Nov 2018||Reviewed||Reviewer Report - Kadoaki Ohashi|
|20 Nov 2018||Reviewed||Reviewer Report - Chong-Rui Xu|
|26 Nov 2018||Author responded||Author comments - Akihiro Yoshimura|
|Resubmission - Version 3|
|26 Nov 2018||Submitted||Manuscript version 3|
|29 Nov 2018||Editorially accepted|
|11 Dec 2018||Article published||10.1186/s12885-018-5153-4|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.